ASC-43F

N/A

Report date: 2024/12/30 15:49:21
NMEFirst In Class

Base Information

Drug NameASC-43F
Drug Alias NameASC43FAS-43FASC41/ASC42
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonistsBile acid receptor FXR agonists
TargetsThyroid hormone receptor betaBile acid receptor FXR
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes ASC-41Danifexor
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGannex Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A